| Keywords: |
treatment outcome; clinical trial; placebo; dose response; drug efficacy; nonhuman; side effect; pathophysiology; drug megadose; low drug dose; opiate; health survey; editorial; dose-response relationship, drug; drug receptor binding; chronic disease; antidepressant agent; nerve injury; sex difference; methadone; morphine; analgesics, opioid; anticonvulsive agent; hydromorphone; analgesia; pain assessment; neuropathic pain; drug tolerance; dose calculation; mu opiate receptor agonist; nociception; dna polymorphism; fentanyl; levorphanol; oxycodone; opiate addiction; neuralgia; allodynia; n methyl dextro aspartic acid receptor; pharmacogenomics; drug cross tolerance; humans; human; priority journal
|
